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ABSTRACT 
3D printing is also known as additive manufacturing, which is the potential way to transform the manufacturing as well formulation in 
pharmaceuticals and biomedical industries. Three-dimensional (3D) Printed medicines are revolutionsing the pharmaceutical market as 
potential tools to achieve personalized treatments adapted to the specific requirements of each patient, taking into account their age, weight, 
comorbidities, pharmacogenetic, and pharmacokinetic characteristics. Additive manufacturing or 3D printing has wide range of techniques 
which are classified in many categories but most commonly used in the 3D printing of medicines are: printing-based inkjet systems, nozzle-
based deposition systems, and laser-based writing systems, in addition to both polymer filaments and hydrogels as materials for drug carriers.  
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INTRODUCTION 
There is always focus towards new concepts in drug design, 
better understanding of material properties, manufacturing 
technology and processes that will assures high quality of 
dosage forms. Within last few decades the patient-centric 
drug product development has been taken under 
considerable attention. The focused on novel dosage forms 
and technological processes has increased. Three 
dimensional printing (3DP) is believed to be the most 
revolutionary and powerful technique for the development 
of novel drug delivery system. This technique is versatile tool 
of precise manufacturing of various devices. It helps in 
serving as a technology tool for developing novel dosage 
forms, tissues and organs engineering as well as disease 
modeling. 
Nowadays, three-dimensional printing is one of the fastest 
developing branches of technology, art and science, and still 
broadens the applications. The term three-dimensional 
printing or 3D printing defined by International Standard 
Organization (ISO) as: fabrication of objects through the 
deposition of a material using a print head, nozzle, or 
another printer technology. In contrast to commonly used 
subtractive and formative manufacturing methodologies, this 
technique is one of the methods of additive manufacturing 
(AM) in which the parts are prepared from 3D model data in 
the process of joining materials layer by layer. The practical 
approach of AM is called rapid prototyping (RP) and its 
advantages include the reduction of prototyping time and 
costs, easy modifications of a product at a designed level, the 
possibility of manufacturing of small objects, individualized 
product series or structures impossible to be formed with 
subtractive techniques. The novel approaches in the 
formulation of solid dosage forms for personalized as well as 
individualized therapy are particularly focused; however 
TDDS as well as biomedical applications of additive 
manufacturing technique including implants, surgical 
models, bioprinted materials and biorobotics is also 
mentioned.1, 2 
Pharmaceutical potentials of 3D printing 
The processes that are traditionally adopted by 
pharmaceutical industries such as milling, mixing, 
granulation and compression sometimes results in uneven 
qualities of the final products depending on the factors such 
as drug loading, drug release, drug stability and 
pharmaceutical dosage form stability. On the other hand, 3D 
printing, as a powerful tool technology, has competitive 
advantages such as improved R and D productivity, 
improved safety, efficacy and accessibility of medicine. The 
major advantages of 3D printing that makes it much more 
attracting are: 
1. Personalization 
The current popularity of 3D printing in various fields is 
often described as a new industrial revolution. While in the 
last centuries industries were focused on mass-
manufacturing, automation and standardization in order to 
reduce costs and increase profit, with the advent of 3D 
printing they are shifting to on-demand production of either 
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a small number of objects or even one object at a time (small 
batches), possibly customized, at affordable prices. Products 
characterized by complex geometries can also be fabricated 
and real-time modified to meet individual needs at little or 
no extra costs. 3D printing is spreading throughout all 
manufacturing stages of production, from the prototyping 
step to the fabrication of consumer products. By shortening 
the design, manufacturing and production cycle, thus 
simplifying the manufacturing chain, this new technology has 
brought the site of object fabrication closer to that of 
demand. Moreover, it has proved effective as a rapid 
prototyping tool useful to evaluate the form, fit and function 
of many objects before their production on a large scale. 
 Personalized medicine: Personalized medicine 
generally consists in tailoring medical treatments to the 
characteristics, needs and preferences of each single 
patient, and it involves purposely run diagnosis, 
therapy and follow-up. The concept could be extended 
to include pre-emptive medicine aimed at reducing the 
risk of diseases a subject has shown susceptible to, by 
changing his lifestyle, diet and habits and by advising 
him on the use of peculiar supplements or drugs. 
 Personalized therapy: In the medical field, 3D printing 
was initially employed by surgeons as an aid in creating 
3D models of patients to better visualize their anatomy, 
particularly in the case of individuals with unique 
structures or anomalies, which would require complex 
surgeries. This technique has partially replaced more 
established ones (e.g. solvent casting and particulate 
leaching, membrane lamination, molding) since it 
enables fabrication, starting from biocompatible 
materials, of items perfectly fitting the anatomical 
characteristics of the patient as highlighted by 
diagnostic imaging tools (e.g. X-ray, computed 
tomography, nuclear magnetic resonance). Scaffolds 
are intended for different functions, such as space 
filling, 3D structures that organize proliferating cells 
into a desired tissue, in situ vehicles for the delivery of 
active molecules (e.g. antibiotic or anti-inflammatory 
drugs, growth factors). 
  
 
Figure 1: Personalized Dosage through Additive Manufacturing 
2. Tailored medication 
3D printing helps in the production of medication as per the 
required needs of the patients or depending upon the 
medication required. The method can be adopted in case of 
pediatrics dose, where the range of dose may vary. Similarly, 
the shape of the dosage form can be altered for the patients 
with swallowing difficulties. 3DP is highly flexible and 
simple method to change the shape and size of the dosage 
form. 
3. Create complex shapes 
3DP allows the formations of complex shapes and that too 
with accurate dose of medication or active pharmaceutical 
ingredients, even as low as 10-12 mole per tablets which 
helps in reducing the side effects which are observed due to 
excessive doses. As compared to conventional methods 
where complex geometries were not possible it can be 
achieved easily by 3D printing. Similarly, different shapes 
and sizes also results in different release profile. Complex 
shapes results in modified release, adjust drug loading and 
mask the taste of the medication. 
4. Sustained release 
Drug release can be easily controlled and targeted by 3D 
printing. It can be adopted by printing a binder in the layers 
of the matrix powder. This creates a barrier between the 
layers of API and allows variation in release profile. 
5. Unique dosage form 
In pharmaceutical production process, 3D printing can be 
used to create unique and limitless dosage forms. 3DP is 
used to create novel dosage forms. 
6. Mini dispenser unit 
The set up for 3D printers require minimal space allowing 
them to fit in any environment, are cost effective. 3D 
printing is a computer aided design that means it can be 
controlled using computer software and network. Moreover, 
3D printing technologies allows individualization of 
medication. These characteristics allows 3D printer to 
function as a mini-dispenser to potentially bring tablet 
manufacturing closer to patients. 
7. Integrated with Health Care Network 
Physicians and pharmacists can modify the next dose or 
drug combinations according to patient’s need. As 3D 
printers are remotely controlled, 3D printing can became 
easily accessible to the patients. Hence, this improves the 
patients’ compliance and shortens the time of clinical 
response to patient’s needs. 
8. Accelerated Disintegration 
3D printing makes a huge difference with powder 
compression in terms of disintegration process. The pattern 
of powder aggregation is different in both the conventional 
and newer method. In 3D printing powder binding strength 
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is higher in the periphery and lowers in the centre which 
leads to rapid disintegration of tablets. Aprecia's Zip Dose® 
has found to disintegrate in less than 10s whilst containing a 
high dose of piracetam (1000 mg). 
9. Tool Less 
3DP can eliminate the need for tool production and 
therefore, reduced cost, lead time and labour associated with 
it. 
10. Sustainable/eco friendly 
3D printing being a new and emerging technology is energy-
efficient and provides environmental eﬃciencies. It utilises 
up to 90% of standard materials, and, therefore, creates less 
waste. It has stronger design that imposes a reduced carbon 
footprint compared with traditionally manufactured 
products. 
11. Short production time 
3D printers are time efficient which shortens the product 
development design cycles. 
12. Manufacturing process 
The manufacturing process is quite easier and cost effective. 
The time of processing is less due to improved tools, less 
waste and takes fewer steps to assemble the setup and also 
reduce lead time via functional integration of parts. 
13. Engineering and Maintenance 
3D printers have more flexible set up and maintenance 
processes. It is cost-efficient industrial engineering. 
14. Logistic 
3D printing is promising tool whereby products can be 
manufactured on demand and place where needed which 
reduces the inventory and logistics handling and moreover 
the transportation and related costs. 3, 5 
USA-FDA approved 3D printed drug products: 
Worldwide 
Aprecia Pharmaceuticals in August 2015 introduced the first 
drug product using the ZipDose technique for the treatment 
of epilepsy. FDA approved the drug product SPRITAM 
levetiracetam for oral use for the treatment of partial 
seizures, primary generalized tonic clonic seizures, 
myoclonic seizures in adults and children. Spritam was 
formulated by ZipDose technology that produced a porous 
formulation that disintegrates rapidly. Spritam was designed 
to fill the needs of the patients who have problems with the 
current medication therapy. ZipDose technology enables the 
incorporation of large doses up to 1000 mg in single dosage 
form. This technology enhanced the patient compliance by 
easy administration of drug. ZipDose technology combines 
the drug formulation science with unique manufacturing 
capabilities of 3D printing. Aprecia pharmaceuticals have the 
FDA approved licence for developing the pharmaceutical 
dosage form worldwide. 5, 6 
 
Table: Fabrication of dosage forms by 3D printing technology 
3D printing Dosage form Drug 
FDM Catheter Nitrofurantoin 
FDM Implant CR Dye 
FDM General Device Gentamicin sulphate, Methotrexate 
FDM Implant Nitrofurantoin, Hydroxyapatite 
Thermal Inkjet printer Tablet Prednisolone 
Inkjet Printing Implant Levofloxacin 
Thermal inkjet printer Solution Salbutamol 
Inkjet printing nanoparticles Rifampicin 
Thermal inkjet printer Solid dispersion Felodipine 
Thermal inkjet printer Nano suspension Folic acid 
Desktop 3D printer Tablet Guaifenesin 
A lab-scale 3DP machine Capsule Pseudoephedrine HCl 
3DP Tablet Acetaminophen 
3DP Multi-drug implant Rifampicin, Isoniazid 
Extrusion printing Tablet Captopril, Nifedipine, Glipizide 
3D printer Microfluidic pump Saline solution 
3D printer Fast-disintegrating Paracetamol 
Stereolithography 3DP Tablets (MR) Paracetamol 
3D printer Biodegradable patch 5-Fluorouracil 
Stereolithography printer Anti-acne patch Salicylic acid 
3D printer Tablets Paracetamol 
Piezoelectric inkjet printer Microparticles Paclitaxel 
CR-controlled release, IR-immediate release, MR-modified release, ER-extended release, IU-Intrauterine, SC-Subcutaneous 
3D Printing Glossary: 7, 8 
 Additive Manufacturing: it is the process of joining 
materials to fabricate or design objects from 3D model 
data, generally layer by layer. 
 Computer-Aided Design: it involves the use of computer 
systems to assist in the creation, modification or 
optimization of 3D drawings for particular drug products. 
 Extrusion: 3D printing process which involves layer by 
layer deposition of molten/softened or liquid/semisolid 
materials through a syringe or a nozzle 
 Fused Deposition Modeling: 3D printing technique that 
involves the use of one or more filaments, generally 
based on a thermoplastic material, which are extruded 
and deposited in a molten/softened state layer by layer 
 Rapid Prototyping: production of a prototype/scale 
model of a physical object/assembly using 3D computer-
aided design data 
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 Resolution: Degree of conformity of a 3D printed object 
to the electronic model by which it was generated 
 Solidification of Powder: 3D printing technique that 
involves the distribution of thin layers of powder 
selectively joined by using drops of a liquid binder 
 Stereolitography: 3D printing technique that involves the 
use of a UV laser to cure a photo-reactive resin, contained 
in a vat, layer by layer into a solid object. 
 .stl FILE: file generated by a computer-aided design 
program that contains all the data describing the layout 
of a 3D object and it is the most commonly used file 
format for 3D printing 
 Subtractive Manufacturing: process in which 3D objects 
are fabricated by successively cutting material away from 
a solid block of the latter. 
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